TScan Therapeutics, Inc 10-Q for FY2023 Q2
TScan Therapeutics, Inc. (TCRX)
10-Q
2023-08-10
For: 2023-06-30
View Original
Added on
April 06, 2026
About this 10-Q
TScan Therapeutics, Inc filed this 10-Q on August 10, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.15M
- down 22.4% from $4.06M a year earlier
- Net loss
- $24.05M
- compared with a net loss of $15.1M a year earlier
- Diluted EPS
- -$0.51
- compared with -$0.63 a year earlier